Enovis Corp
NYSE:ENOV
Operating Margin
Enovis Corp
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Enovis Corp
NYSE:ENOV
|
2.1B USD |
1%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
228B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.8B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
147.9B USD |
18%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
142B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.6B USD |
19%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
65.6B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
56.1B EUR |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
42.3B USD |
27%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
286.9B CNY |
36%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.4B USD |
13%
|
Enovis Corp
Glance View
Enovis Corp., a company with a steadfast commitment to innovation and growth, operates within the specialized world of medical technology. Originally a part of Colfax Corporation, it underwent a strategic transformation, branching out into its own entity, laser-focused on advancing human mobility through cutting-edge orthopedic solutions. Enovis has carved its niche by developing and manufacturing high-quality, bespoke orthopedic products that serve both surgical and non-surgical needs. These offerings are designed to enhance patient recovery and mobility, thereby improving quality of life. Its extensive product portfolio includes surgical implants, bracing, rehabilitation solutions, and intelligent digital care platforms, positioning Enovis at the intersection of healthcare and technology. Revenue for Enovis streams from its diverse array of products and solutions targeted at healthcare professionals and institutions worldwide. The company thrives by engaging in both direct sales and a network of distributors to ensure its innovative solutions reach a broad spectrum of the healthcare landscape. By continually investing in research and development, Enovis maintains its competitive edge, launching new products that address evolving medical needs. This proactive approach not only caters to the existing demand but also stimulates new markets by educating and training medical professionals and leading them through transformative, evidence-based clinical outcomes. In essence, Enovis Corp. excels by integrating science and technology to fuel both financial growth and human betterment.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Enovis Corp's most recent financial statements, the company has Operating Margin of 0.6%.
You don't have any saved screeners yet